Erinle Pharma Private Limited - Company Profile

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2016.
2016 Bangalore, Karnataka, India Active
Last Updated:
About Erinle Pharma Private Limited

Erinle Pharma Private Limited, a active private limited company, was established on 03 August 2016 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24239KA2016PTC095489. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Venkatachalam Srinivasulu Nagaraju (Director), Shridevi (Director). Its latest AGM occurred on 27 September 2019, with the balance sheet filed on 31 March 2019. It is based at No:363, 1St B Main, 2Nd Cross, Jayanagar 7Th Block West,, Bangalore, Karnataka, 560070.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239KA2016PTC095489

  • Registration Number

    095489

  • Incorporation Date

    03 August 2016

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 6 Months
  • Last Filing with ROC 31 Mar 2019
Company report

Erinle Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Erinle Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Erinle Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Venkatachalam Srinivasulu Nagaraju Director 03 Aug 2016 Current
Shridevi Director 03 Aug 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Erinle Pharma.

Erinle Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Erinle Pharma revenue growth over time
Erinle Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Erinle Pharma?

In 2017, Erinle Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Erinle Pharma?

Unlock and access historical data on people associated with Erinle Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Erinle Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erinle Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Erinle Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Erinle Pharma Private Limited last Annual general meeting of members was held on 27 Sep 2019 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Erinle Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Bangalore. was completed.

  • Director Appointment

    Progress on Venkatachalam Srinivasulu Nagaraju was appointed as a Director was appointed as a Director on 03 Aug 2016 & has been associated with this company since 9 years 6 months . was documented.

  • Director Appointment

    Shridevi was appointed as a Director was appointed as a Director on 03 Aug 2016 & has been associated with this company since 9 years 6 months . was recorded as a recent event.

  • Company Incorporation

    The activity Erinle Pharma Private Limited was registered on 03 Aug 2016 with Roc Bangalore & aged 9 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Erinle Pharma Private Limited?

The CIN of Erinle Pharma Private Limited is U24239KA2016PTC095489.

Where is Erinle Pharma Private Limited headquartered?

Erinle Pharma Private Limited is headquartered at No:363, 1St B Main, 2Nd Cross, Jayanagar 7Th Block West,, Bangalore, Karnataka, 560070.

When was Erinle Pharma Private Limited incorporated?

Erinle Pharma Private Limited was incorporated on 03 August 2016.

Who are the current directors of Erinle Pharma Private Limited?

The current directors of Erinle Pharma Private Limited are

What is the primary industry of Erinle Pharma Private Limited?

The primary industry of Erinle Pharma Private Limited is Pharma.

Is Erinle Pharma Private Limited a listed company?

Erinle Pharma Private Limited is unlisted.

What is the capital structure of Erinle Pharma Private Limited?

The authorized capital of Erinle Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Erinle Pharma Private Limited?

The compliance status of Erinle Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available